Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Trading Statement

27 Jan 2010 07:00

RNS Number : 1723G
Plant Health Care PLC
27 January 2010
 



For release: 7am, 27 January 2010 

 

PLANT HEALTH CARE PLC

("Plant Health Care" or "the Company")

Trading Update

Plant Health Care (AIM: PHC.L), a leading provider of naturally derived products to the agriculture and landscape industries, provides the following post year end update for 2009, ahead of the announcement of its full year results, which is expected on 15 February 2010.

The Company is pleased to announce that it has continued to make excellent progress with its strategic priorities, particularly in its relationships with Monsanto and Scotts. Furthermore, despite difficult trading conditions in the United States as a result of the recessionary economic climate and following the pre-tax loss of $3.9 million incurred in the first half of the year, the Company has traded profitably in the last six months. In consequence, the Company expects to report a significantly reduced full year lossin line with market expectations.

The Company has continued to make excellent progress in its partnership with Monsanto with significantly larger orders placed for Harpin (for use on Soybean), during 2009, than had originally been expected. Moreover, it continues to be in discussions regarding the use of Harpin on other crops than soybean and remains confident of reaching a conclusion to those discussions before the end of the Summer, with a consequent positive impact on the company's earnings in 2010.

As relationships with the Company's major customers have developed it has become clear that in the future, they will wish to align the timing of their purchasing of Harpin and other products more closely with their use. The Board is therefore adjusting its market guidance for 2010, and beyond, to recognise that at least one third of sales previously expected to fall in 2010 are now likely to fall in to the following year.

The cash position as at 31 December 2009 was $15.9 million (2008: $7.3 million), benefitting from tight cash management and the £10.5 million of new funds raised from the placing in May 2009.

The Company continues to be in advanced discussions with a wide variety of potential partners for both Harpin, as a foliar spray in combination with herbicides and fungicides, and for Myconate and remains confident that it will be in a position to conclude partnership deals on both these products before the end of 2010. 

John Brady, Chief Executive of Plant Health Care said: "2009 was an excellent year for Plant Health Care. For the first time one of our natural technologies will be on millions of acres and interest in our sustainable, naturally derived technologies is high. I look forward to providing more detail to our shareholders in February.

-Ends-

For further information please contact:

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Evolution Securities

Tavistock Communications 

Tim Worlledge / Tim Redfern

Jeremy Carey/Matt Ridsdale

Tel: +44-20-7071-4300 

Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com/

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk

mridsdale@tavistock.co.uk


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVALFIRFII
Date   Source Headline
14th Sep 20157:00 amRNSHalf Yearly Report
19th Aug 20157:00 amRNSBlocklisting Interim Review
13th Jul 20157:00 amRNSPHC Granted Product Registration in Brazil
18th Jun 20157:00 amRNSDirector/PDMR Shareholding
17th Jun 20152:20 pmRNSResult of AGM
2nd Jun 20157:00 amRNSRe Agreement
6th May 20157:01 amRNSPlant Health Care Hires Jeff Tweedy
30th Apr 20153:02 pmRNSTotal Voting Rights
22nd Apr 20153:05 pmRNSTR1: Notificiation of Major Interest in Shares
17th Apr 20157:00 amRNSDIRECTORS' DEALING
15th Apr 20157:00 amRNSAnnual Report 2014 and Notice of AGM
8th Apr 20157:00 amRNSRe Agreement
30th Mar 20157:00 amRNSAnnual Financial Report
27th Mar 20157:00 amRNSDirectorate Change
5th Mar 201512:30 pmRNSPlant Health Care signs Distribution Agreement
20th Feb 20155:48 pmRNSBlocklisting Interim Review
17th Feb 20154:03 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSBoard changes and trading update
15th Dec 20141:51 pmRNSTR-1: Notification of Major Interest in Shares
5th Dec 20147:00 amRNSPHC Signs Agreement With Arysta LifeScience
19th Nov 20147:00 amRNSPlant Health Care Hires LHA
11th Nov 20144:05 pmRNSHolding(s) in Company
30th Oct 20147:00 amRNSPHC & Sipcam Enter Agreement
27th Oct 20147:00 amRNS3G Peptide Technology Platform shows major promise
23rd Oct 20144:29 pmRNSHolding(s) in Company
6th Oct 201411:25 amRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSDirector/PDMR Shareholding
15th Sep 20147:00 amRNSHalf Yearly Report
19th Aug 201410:28 amRNSAIM Blocklisting Return
12th Aug 20143:10 pmRNSTR-1 Notification of Major Interest in Shares
22nd Jul 20144:10 pmRNSTR-1 Notification of Major Interest in Shares
30th Jun 20149:18 amRNSTotal Voting Rights
5th Jun 201412:45 pmRNSTR-1 Notification of Major Interest in Shares
22nd May 20147:00 amRNSDelisting of shares from the CISX
8th May 20141:30 pmRNSAGM Voting Results
15th Apr 201411:30 amRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSDirector/PDMR Shareholding
9th Apr 20142:15 pmRNSDirector's Dealing - Grant of Share Options
9th Apr 20142:00 pmRNSTR-1 Notification of Major Interest in Shares
7th Apr 20145:15 pmRNSPublication of Annual Report 2013 & Notice of AGM
31st Mar 20143:45 pmRNSTotal Voting Rights
24th Mar 20147:00 amRNSPreliminary Results
3rd Mar 20144:35 pmRNSPrice Monitoring Extension
28th Feb 20141:00 pmRNSTotal Voting Rights
19th Feb 201412:15 pmRNSBlocklisting Interim Review
17th Feb 20149:45 amRNSTR-1 Notification of Major Interest in Shares
6th Feb 20144:40 pmRNSSecond Price Monitoring Extn
6th Feb 20144:35 pmRNSPrice Monitoring Extension
31st Jan 20143:00 pmRNSTotal Voting Rights
15th Jan 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.